30.14
price up icon3.57%   1.04
after-market アフターアワーズ: 30.05 -0.09 -0.30%
loading
前日終値:
$29.10
開ける:
$29.26
24時間の取引高:
532.57K
Relative Volume:
3.41
時価総額:
$498.45M
収益:
$3.25M
当期純損益:
$-116.80M
株価収益率:
-9.882
EPS:
-3.05
ネットキャッシュフロー:
$-98.17M
1週間 パフォーマンス:
+14.25%
1か月 パフォーマンス:
+166.73%
6か月 パフォーマンス:
+239.41%
1年 パフォーマンス:
+89.32%
1日の値動き範囲:
Value
$28.07
$31.76
1週間の範囲:
Value
$24.34
$31.76
52週間の値動き範囲:
Value
$5.6652
$31.76

Rapt Therapeutics Inc Stock (RAPT) Company Profile

Name
名前
Rapt Therapeutics Inc
Name
セクター
Healthcare (1145)
Name
電話
(650) 489-9000
Name
住所
561 ECCLES AVENUE, SOUTH SAN FRANCISCO, CA
Name
職員
61
Name
Twitter
Name
次回の収益日
2024-11-11
Name
最新のSEC提出書
Name
RAPT's Discussions on Twitter

RAPT を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
RAPT
Rapt Therapeutics Inc
30.14 481.25M 3.25M -116.80M -98.17M -3.05
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
403.30 104.83B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
600.00 63.59B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.35 60.43B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
ARGX
Argen X Se Adr
800.00 48.45B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
343.87 37.91B 4.56B -176.77M 225.30M -1.7177

Rapt Therapeutics Inc Stock (RAPT) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-26 アップグレード Leerink Partners Market Perform → Outperform
2025-07-30 アップグレード JP Morgan Underweight → Neutral
2025-05-22 再開されました H.C. Wainwright Buy
2024-12-26 アップグレード H.C. Wainwright Neutral → Buy
2024-11-13 ダウングレード Stifel Buy → Hold
2024-11-11 ダウングレード JP Morgan Neutral → Underweight
2024-11-11 ダウングレード Piper Sandler Overweight → Neutral
2024-05-14 ダウングレード Wolfe Research Outperform → Peer Perform
2024-05-10 ダウングレード Barclays Overweight → Equal Weight
2024-05-10 ダウングレード Guggenheim Buy → Neutral
2024-02-22 ダウングレード UBS Buy → Neutral
2024-02-21 ダウングレード H.C. Wainwright Buy → Neutral
2024-02-21 ダウングレード JP Morgan Overweight → Neutral
2024-02-21 ダウングレード Leerink Partners Outperform → Market Perform
2024-02-20 ダウングレード Cantor Fitzgerald Overweight → Neutral
2024-02-16 開始されました Evercore ISI Outperform
2024-02-15 開始されました Wolfe Research Outperform
2023-09-14 開始されました Berenberg Buy
2023-08-09 開始されました Stifel Buy
2023-06-15 開始されました Barclays Overweight
2023-01-04 開始されました Guggenheim Buy
2022-12-01 開始されました Goldman Buy
2022-09-21 開始されました CapitalOne Overweight
2022-05-24 再開されました Cantor Fitzgerald Overweight
2021-12-09 開始されました JP Morgan Overweight
2021-08-12 開始されました SVB Leerink Outperform
2021-06-21 開始されました Piper Sandler Overweight
2020-06-01 開始されました H.C. Wainwright Buy
2020-05-19 開始されました Cantor Fitzgerald Overweight
2020-04-13 開始されました ROTH Capital Buy
2019-11-25 開始されました BMO Capital Markets Outperform
2019-11-25 開始されました UBS Buy
2019-11-25 開始されました Wells Fargo Outperform
すべてを表示

Rapt Therapeutics Inc (RAPT) 最新ニュース

pulisher
08:21 AM

Why RAPT Therapeutics Inc. stock is seen as undervaluedQuarterly Investment Review & Free Reliable Trade Execution Plans - newser.com

08:21 AM
pulisher
08:04 AM

How analysts rate RAPT Therapeutics Inc. stock today2025 Investor Takeaways & Risk Managed Trade Strategies - newser.com

08:04 AM
pulisher
06:17 AM

Why RAPT Therapeutics Inc. (0RA0) stock stays on top picksWeekly Gains Report & Free Daily Entry Point Trade Alerts - newser.com

06:17 AM
pulisher
06:03 AM

Is RAPT Therapeutics Inc. (0RA) stock bottoming after sell offQuarterly Profit Summary & High Conviction Buy Zone Picks - newser.com

06:03 AM
pulisher
Oct 03, 2025

How RAPT Therapeutics Inc. (0RA) stock performs in volatility spikesJuly 2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Will RAPT Therapeutics Inc. stock maintain growth story2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Can swing trading help recover from RAPT Therapeutics Inc. lossesJuly 2025 Fed Impact & Community Consensus Picks - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How to use a screener to detect RAPT Therapeutics Inc. breakoutsFed Meeting & Comprehensive Market Scan Reports - newser.com

Oct 03, 2025
pulisher
Oct 02, 2025

Published on: 2025-10-02 21:38:33 - newser.com

Oct 02, 2025
pulisher
Sep 30, 2025

Will RAPT Therapeutics Inc. (0RA) stock draw ESG focused fundsRisk Management & Daily Profit Focused Screening - newser.com

Sep 30, 2025
pulisher
Sep 30, 2025

Clear Street Maintains RAPT Therapeutics (RAPT) Buy Recommendation - Nasdaq

Sep 30, 2025
pulisher
Sep 30, 2025

Published on: 2025-09-30 02:47:57 - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

Rapt Therapeutics stock price target raised to $41 from $24 at Clear Street - Investing.com Canada

Sep 29, 2025
pulisher
Sep 29, 2025

What hedge fund moves indicate for RAPT Therapeutics Inc. (0RA) stockJuly 2025 Macro Moves & Weekly Consistent Profit Watchlists - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

RAPT Therapeutics stock rises after FDA clears IND for food allergy trial By Investing.com - Investing.com Nigeria

Sep 29, 2025
pulisher
Sep 29, 2025

RAPT Therapeutics stock rises after FDA clears IND for food allergy trial - Investing.com Nigeria

Sep 29, 2025
pulisher
Sep 29, 2025

RAPT Therapeutics Announces FDA Clearance of IND - GlobeNewswire

Sep 29, 2025
pulisher
Sep 29, 2025

Rapt Therapeutics announces FDA clearance to proceed to phase 2b trial of RPT904 in food allergy - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

RAPT Therapeutics' Food Allergy Drug Gets FDA Clearance for Phase 2b Trial - MarketScreener

Sep 29, 2025
pulisher
Sep 29, 2025

RAPT Therapeutics Announces FDA Clearance of IND Application to Proceed to Phase 2b Trial of RPT904 in Food Allergy - The Manila Times

Sep 29, 2025
pulisher
Sep 29, 2025

RAPT Therapeutics Announces FDA Clearance for IND Application to Initiate Phase 2b Trial of RPT904 in Food Allergy Treatment - Quiver Quantitative

Sep 29, 2025
pulisher
Sep 29, 2025

How to build a dashboard for RAPT Therapeutics Inc. stockJuly 2025 Sector Moves & AI Driven Stock Movement Reports - newser.com

Sep 29, 2025
pulisher
Sep 29, 2025

FDA Green Light: RAPT Therapeutics' Novel Food Allergy Treatment Heads to Critical Phase 2b Trial - Stock Titan

Sep 29, 2025

Rapt Therapeutics Inc (RAPT) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$21.43
price up icon 2.68%
$86.85
price up icon 0.66%
$33.56
price up icon 4.48%
$105.49
price up icon 0.94%
$157.16
price up icon 2.85%
biotechnology ONC
$343.87
price down icon 0.38%
大文字化:     |  ボリューム (24 時間):